A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.


Updates from The Motley Fool

Latest updates on Synta Pharmaceuticals from Fool.com.


Stock Performance

SNTA vs. S&P 500 | 2 Year Performance
View Interactive SNTA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Synta Pharmaceuticals.
Current Price: $11.99
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $1.65B
P/E (ttm): 0.00
EPS (ttm): -$0.26
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Synta Pharmaceuticals.
CAPS Rating 3 out of 5
 
164 Outperform
30 Underperform
CAPS All Stars
 
22 Outperform
7 Underperform

How do you think Synta Pharmaceuticals will perform against the market?



You pick for Synta Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Chen Schor, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Synta Pharmaceuticals.

A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers